Generic name: Entecavir Tablets

[Indication]: This product is indicated for the treatment of chronic adult hepatitis B (including patients with compensated and decompensated liver disease) with active viral replication, persistently elevated serum alanine aminotransferase (ALT) or histological evidence of active liver disease. See the package insert for details 

[Strength]: 0.5 mg, 1.0 mg

[Storage] Store in a tightly-closed container in a dry place below 25℃, allow for short-term exposure to 15-30℃.

[Packaging] Double aluminum blister packing (pharmaceutical aluminum foil, polyamide/aluminum/polyvinyl chloride cold stamping solid pharmaceutical composite sheet), 7 tablets/plate, 1 plate/box; 7 tablets/plate, 2 plates/box; 7 tablets/plate, 4 plates/box.

[Shelf Life] 24 months

[Approval No.] 0.5 mg: GYZZ H20203708, 1 mg: GYZZ H20203709

[Drug Marketing Authorization Holder] Guangzhou Bostal Drug Delivery Co., Ltd

[Manufacturer] Guangzhou Bostal Drug Delivery Co., Ltd

For more information please refer to the package insert.

  Cooperation Contact: Marketing Center: Marketing@bostaldrug.com